Abstract
Variants in MBTPS1 (membrane-bound transcription factor peptidase, site 1) encoding the protein convertase site-1 protease (S1P) were recently reported in a single individual with skeletal dysplasia and elevated plasma lysosomal enzymes. Here, we report the second individual with this newly described autosomal recessive spondyloepiphyseal dysplasia (OMIM #618392), presenting severe growth retardation, cataract and dysmorphic features, mainly retromicrognathia. Epilepsy and craniosynostosis were novel findings in our proband. She was found to be homozygous for a novel nonsense variant p.Trp983Ter in MBTPS1. In addition, she had normal levels of lysosomal enzyme activity in leukocytes but elevated levels in plasma. Our description confirms the existence of this new skeletal dysplasia and expands the phenotype and genotype of the disease.
Original language | English (US) |
---|---|
Pages (from-to) | 1796-1800 |
Number of pages | 5 |
Journal | American Journal of Medical Genetics, Part A |
Volume | 182 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2020 |
Keywords
- MBTPS1
- cataract
- retromicrognathia
- site-1 protease (S1P)
- spondylepimetaphyseal dysplasia
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)